Inhibikase Therapeutics, Inc. - COM NEW (IKT)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / COM NEW
Number of holders
13
Total Shares
430K
Shares change
-317K
Total reported value, excl. options
$598K
Value change
-$497K
Put/Call ratio
0
Number of buys
9
Number of sells
-5
Price
$1.39
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.